Thiruppugazh Nutrabioceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-05-2024
- Paid Up Capital ₹ 0.60 M
as on 20-05-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 95.36%
(FY 2020)
- Profit 95.94%
(FY 2020)
- Ebitda 936.39%
(FY 2020)
- Net Worth 89.68%
(FY 2020)
- Total Assets 82.67%
(FY 2020)
About Thiruppugazh Nutrabioceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Marimuthu Chandramohan and Priya Rajendran serve as directors at the Company.
- CIN/LLPIN
U15138TZ2018PTC030901
- Company No.
030901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Erode, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Thiruppugazh Nutrabioceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Marimuthu Chandramohan  | Managing Director | 05-Sep-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priya Rajendran | Director | 05-Sep-2018 | Current |
Financial Performance of Thiruppugazh Nutrabioceuticals.
Thiruppugazh Nutrabioceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 95.36% increase. The company also saw a substantial improvement in profitability, with a 95.94% increase in profit. The company's net worth Soared by an impressive increase of 89.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thiruppugazh Nutrabioceuticals?
Unlock access to Thiruppugazh Nutrabioceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Microcore Research Laboratories India Private LimitedActive 17 years 8 monthsMarimuthu Chandramohan and Priya Rajendran are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thiruppugazh Nutrabioceuticals?
Unlock and access historical data on people associated with Thiruppugazh Nutrabioceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thiruppugazh Nutrabioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thiruppugazh Nutrabioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
